The next 6 -8 weeks appear to be the crescendo of the MSB Journey! COVID-19 trial, CHF and back pain readouts. I feel that the risk is somewhat mitigated due to Grunenthal partnership for back pain. The previously published data on Revascor CHF and last but not least the 12 patient study and the confidence of SI in various interviews as well as the cap raising for increased manufacturing prior to outcome of 300 patient trial.
IF the results of all 3 are relatively positive the SP should be close to $20. Not long to wait to find out the outcome!!!
GLTAH
MSB Trading - 2020, page-10080
-
- There are more pages in this discussion • 13,081 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |